Akums Drugs and Pharmaceutical (AKUMS) — Working Capital to Net Assets Ratio
Akums Drugs and Pharmaceutical (AKUMS) has a Working Capital to Net Assets ratio of 74.0% as of March 2026. Working capital of Rs24.65 Billion (current assets of Rs35.60 Billion minus current liabilities of Rs10.95 Billion) is measured against net assets of Rs33.31 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can Akums Drugs and Pharmaceutical fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Akums Drugs and Pharmaceutical Working Capital to Net Assets (2022–2026)
This chart shows how Akums Drugs and Pharmaceutical's Working Capital to Net Assets ratio has evolved across 5 annual periods from 2022 to 2026. As of March 2026, the ratio stands at 74.0%, reflecting working capital of Rs24.65 Billion against net assets of Rs33.31 Billion INR. For the complete balance sheet picture, see AKUMS current and non-current assets.
Annual Working Capital to Net Assets for Akums Drugs and Pharmaceutical (2022–2026)
The table below presents the year-by-year Working Capital to Net Assets ratio for Akums Drugs and Pharmaceutical from 2022 to 2026, covering 5 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check asset resilience ratio of Akums Drugs and Pharmaceutical to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (INR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2026 | 74.0% | Rs24.65 Billion | Rs33.31 Billion | Rs35.60 Billion | Rs10.95 Billion | ▲ +28.9 pp |
| 2025 | 45.1% | Rs13.81 Billion | Rs30.64 Billion | Rs22.75 Billion | Rs8.94 Billion | ▼ -56.3 pp |
| 2024 | 101.4% | Rs7.30 Billion | Rs7.20 Billion | Rs19.41 Billion | Rs12.11 Billion | ▲ +10.3 pp |
| 2023 | 91.0% | Rs6.59 Billion | Rs7.23 Billion | Rs19.24 Billion | Rs12.66 Billion | ▼ -8.0 pp |
| 2022 | 99.0% | Rs6.19 Billion | Rs6.25 Billion | Rs18.92 Billion | Rs12.72 Billion | — |